Lv57
890 积分 2026-03-16 加入
Post-progression treatment options after CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer
11小时前
已完结
Elacestrant in metastatic breast cancer: current advancements and future perspectives
11小时前
待确认
Small Molecule‐Drug Conjugates: Opportunities for the Development of Targeted Anticancer Drugs
1天前
已完结
Small molecule-drug conjugates: A novel strategy for cancer-targeted treatment
1天前
已完结
Small Molecule-Drug Conjugates: An Emerging Drug Design Strategy for Targeted Therapeutics
1天前
已完结
Current landscape and recent developments of PI3K/AKT/mTOR targeted inhibitors for breast carcinoma
1天前
已完结
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
1天前
已完结
Decoding the Genetic Hallmarks of Breast Cancer: Molecular Signatures, Prognostic and Therapeutic Perspectives
1天前
求助中
Epigenetic enzyme inhibitors targeting DNA, histone, and RNA methylation: Mechanisms and therapeutic applications in cancer
1天前
求助中
Synthetic routes and clinical application of Small-Molecule HER2 inhibitors for cancer therapy
1天前
已完结
皖公网安备34019202002308
